Novateor Research Laboratories quarterly results and financials

Novateor Research Laboratories (BSE 542771)Personal Care

Key facts

In the Mar 2026 quarter (standalone), Novateor Research Laboratories reported sales of ₹1.37 Cr, down 30.5% from Mar 2025, and net profit of ₹0.13 Cr, up 116.7% year on year. For the year to Mar 2026, sales were ₹3.84 Cr and net profit ₹0.11 Cr.

Sales (Mar 2026): ₹1.37 Cr
Net profit (Mar 2026): ₹0.13 Cr
Sales (FY Mar 2026): ₹3.84 Cr
Net profit (FY Mar 2026): ₹0.11 Cr
EPS (Mar 2026): ₹0.19
Borrowings (Mar 2026): ₹1.04 Cr

Company filings, standalone accounts; latest reported quarter Mar 2026

Novateor Research Laboratories quarterly results

₹ crore unless stated; each column is a quarter.

Novateor Research Laboratories Quarterly results
	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Sales	0.45	0.37	0.86	0.80	1.97	2.48	1.37
Expenses	0.59	0.54	1.01	0.91	2.01	2.60	1.36
Operating Profit	−0.13	−0.16	−0.14	−0.10	−0.01	−0.11	0.00
OPM %	−31.7%	−47.2%	−17.6%	−13.8%	−1.0%	−4.8%	0.7%
Other Income	0.26	0.23	0.25	0.23	0.23	0.26	0.25
Interest	0.04	0.03	0.02	0.03	0.06	0.06	0.05
Depreciation	0.03	0.03	0.03	0.05	0.09	0.08	0.08
Profit before tax	0.03	0.00	0.03	0.04	0.06	0.00	0.11
Tax %	0.0%	0.0%	0.0%	20.0%	28.6%	99.9%	8.3%
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit	0.04	0.02	0.05	0.04	0.06	−0.03	0.13
EPS (Rs)	0.05	0.01	0.07	0.05	0.09	−0.02	0.19

Novateor Research Laboratories profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Novateor Research Laboratories Profit and loss
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales	0.03	0.11	0.15	0.10	0.42	0.40	0.20	0.75	1.27	1.22	2.77	3.84
Expenses	0.03	0.12	0.09	0.05	0.14	0.54	0.53	0.93	1.61	1.55	2.93	3.94
Operating Profit	0.00	0.00	0.05	0.04	0.27	−0.13	−0.32	−0.17	−0.33	−0.32	−0.13	−0.09
OPM %	0.0%	−9.9%	42.9%	55.6%	68.4%	−35.9%	−173.6%	−24.3%	−26.9%	−27.2%	−5.0%	−2.6%
Other Income	0.00	0.02	0.03	0.04	0.10	0.26	0.45	0.02	0.50	0.50	0.47	0.50
Interest	0.00	0.00	0.02	0.02	0.00	0.02	0.00	0.00	0.03	0.04	0.08	0.10
Depreciation	0.00	0.00	0.06	0.06	0.09	0.09	0.09	0.08	0.08	0.07	0.15	0.18
Profit before tax	0.00	0.00	0.00	0.00	0.28	0.01	0.00	−0.25	0.03	0.04	0.10	0.10
Tax %	—	—	—	—	24.1%	150.0%	0.0%	−11.6%	0.0%	40.0%	27.3%	18.1%
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	−0.48	0.00	0.00	0.00	0.00
Net Profit	0.00	0.00	0.00	0.00	0.23	−0.02	0.02	−0.24	0.05	0.04	0.09	0.11
EPS (Rs)	0.00	0.00	0.00	0.00	0.73	−0.01	0.01	−0.47	0.07	0.05	0.16	0.16
Dividend payout %	—	—	—	—	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Novateor Research Laboratories balance sheet

₹ crore, at each year end.

Novateor Research Laboratories Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	0.05	0.05	0.06	0.06	2.96	4.84	4.84	4.83	4.83	4.84	4.83	6.05
Reserves	0.88	0.88	0.89	0.89	1.11	3.74	3.75	3.01	3.04	3.94	5.71	5.46
Borrowings	0.75	0.76	0.86	0.81	0.02	0.00	0.23	0.25	0.83	1.10	0.90	1.04
Other Liabilities	0.12	0.16	0.10	0.09	0.24	0.22	0.17	0.06	0.24	0.58	1.15	1.73
Total Liabilities	1.80	1.85	1.91	1.85	4.33	8.80	8.99	8.15	8.94	10.46	12.59	14.28
Fixed Assets	1.60	1.65	1.67	1.60	3.56	3.46	3.37	1.95	1.79	2.44	3.40	3.25
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.42	0.43	0.00	0.00
Investments	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02
Other Assets	0.18	0.18	0.22	0.23	0.75	5.32	5.60	6.18	6.71	7.57	9.17	11.01
Inventories	0.11	0.11	0.13	0.16	0.54	0.47	0.50	0.51	0.57	0.71	0.76	1.06
Trade receivables	0.01	0.05	0.06	0.05	0.14	0.24	0.19	0.42	0.69	1.11	2.06	2.81
Cash & equivalents	0.00	0.02	0.00	0.03	0.03	0.70	0.67	0.49	0.23	0.10	0.28	0.48
Total Assets	1.80	1.85	1.91	1.85	4.33	8.80	8.99	8.15	8.94	10.46	12.59	14.28

Novateor Research Laboratories cash flow

₹ crore, for each year.

Novateor Research Laboratories Cash flow
	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	0.02	0.06	−0.08	−3.43	−0.28	−0.98	−0.98	−0.99	−1.04	−0.19
Cash from investing activity	−0.02	0.00	−1.97	−0.11	−0.10	0.92	0.14	−0.26	−0.23	−0.51
Cash from financing activity	0.00	−0.04	2.04	4.19	0.33	−0.12	0.59	1.11	1.42	0.90
Net cash flow	0.00	0.01	0.00	0.66	−0.03	−0.17	−0.25	−0.12	0.17	0.19
Capex	0.00	0.00	1.95	0.09	0.08	0.00	0.35	0.73	0.69	0.01
Free cash flow	0.00	0.04	−2.02	−3.51	−0.35	−0.05	−1.32	−1.71	−1.72	−0.19
CFO / OP %	17.1%	100.1%	0.0%	2,443.0%	82.1%	539.0%	285.1%	297.0%	736.1%	180.1%

Novateor Research Laboratories ratios

Working-capital days and returns, by year.

Novateor Research Laboratories Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	364	218	182	242	133	233	383	211	202	337	271	268
Inventory days	4,381	439	1,461	2,738	6,449	702	853	345	216	270	152	153
Days payable	1,459	291	729	1,094	1,459	14	103	20	60	206	176	208
Cash conversion cycle	3,286	366	914	1,887	5,123	921	1,133	537	357	400	247	213
Working capital days	1,278	110	287	527	463	4,118	9,067	2,747	1,605	1,879	951	771
ROCE %	0.0%	0.0%	0.6%	0.6%	9.9%	0.5%	0.1%	2.5%	0.7%	0.9%	1.7%	1.7%

Novateor Research Laboratories: frequently asked questions

What are the latest quarterly results of Novateor Research Laboratories?

For the Mar 2026 quarter, Novateor Research Laboratories reported sales of ₹1.37 Cr, down 30.5% year on year and net profit of ₹0.13 Cr, up 116.7% year on year. The operating margin was 0.7%.

What is the annual revenue of Novateor Research Laboratories?

Novateor Research Laboratories' sales for the year to Mar 2026 were ₹3.84 Cr.

What is the net profit of Novateor Research Laboratories?

Net profit for the year to Mar 2026 was ₹0.11 Cr. Earnings per share over the same trailing period were ₹0.16.

How much debt does Novateor Research Laboratories have?

Novateor Research Laboratories reported borrowings of ₹1.04 Cr at Mar 2026, against cash and equivalents of ₹0.48 Cr.

What is the free cash flow of Novateor Research Laboratories?

Cash from operations was −₹0.19 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹0.19 Cr.

Loading…